Cg Bio Co., Ltd.

The Asan Foundation

Seok Beom Song

Hyun Seung Ryu

Jun Hyuk Seo

Byoung Suck Kim

Tae Il Kim

Jun Kyu Park

Chang Hun Kum

Deok Hee Lee

Gyu Hyun Jin

Jung Won So

Jae Hwa Cho

Han Ki Kim

Goo Won Jeong

Baek-Hyun Kim

Hyo Jung Kang

Jae Deuck Jung

Seon Moon Hwang

Ok Kyun Lim

Ga Young Lee

The present invention relates to a glass ceramic composition comprising SiO, Ca(OH), CaF, BO, MgO, and hydroxyapatite; a bioactive crystallized glass ceramic comprising each of CaSiO, Ca(PO)(OH), and CaMgSiOin an amount of 20% to 60% by weight; an implant for early osseointegration comprising the glass ceramic; and a method for manufacturing the implant.

Bioactive crystallized glass ceramic comprising wollastonite, hydroxyapatite and diopside, and use thereof

A hybrid stent includes multiple main cells aligned in a spiral shape and including multiple first link units which are aligned diagonally and spaced at a predetermined distance from each other and multiple second link units which connect adjacent first link units among the multiple first link units and are spaced at a predetermined distance from each other, and one or more open cells adjacent to the multiple main cells in a longitudinal direction and aligned in a spiral shape.

Hybrid stent

The present invention relates to a bone-repair composition comprising a micro-pulverized demineralized bone matrix; a nonmicro-pulverized demineralized bone matrix; and a hydrating material. The bone-repair composition of the present invention provides easier injectability and shape-maintenance (handling), and exhibits excellent bone-repairing effects due to a large surface area of the micro-pulverized demineralized bone matrix and an early release of the bone growth factors, compared with conventional compositions comprising the nonmicro-pulverized demineralized bone matrix alone. It also has an advantage of being biocompatible and harmless to the human body because there is no use of synthetic materials.

Bone-repair composition

The present invention relates to a cleaning composition for removing cellular components from tissue for transplantation derived from humans and animals. More particularly, the present invention relates to a cleaning composition for treating tissue for transplantation comprising a polyoxyethyleneglycol C-Calkyl ether as a first protein solubilizing component, a C-Calkylphenol polyethoxylate as a first lipid solubilizing component, a C-Calkyl glycoside as a second protein solubilizing component and a C-Calkylphenoxy polyethoxy ethanol as a second lipid solubilizing component.

Cleaning composition for treating tissue for transplantation derived from human/animal

Growing community of inventors

Seongnam, South Korea

Seok Beom Song